Alternative exon usage and processing of the major histocompatibility complex-encoded proteasome subunits

Area of Science:

• Immunology
• Molecular Biology
• Proteasome Biology

Background:

• The proteasome is crucial for intracellular antigen processing and presentation.
• Two proteasome subunits, LMP2 and LMP7, are encoded within the Major Histocompatibility Complex (MHC).

Purpose of the Study:

• To characterize a novel form of the human LMP7 cDNA, designated LMP7-E2.
• To investigate the genome organization and expression of LMP7.
• To elucidate the relationship between LMP2, LMP7, and proteasome function.

Main Methods:

• cDNA cloning and characterization.
• Genome organization analysis.
• Immunoblotting using specific antibodies against LMP2 and LMP7.
• Analysis of protein processing and complex incorporation.

Main Results:

• A second form of human LMP7 cDNA, LMP7-E2, was identified, arising from alternative exon usage of the LMP7 gene.
• LMP2 and LMP7 are co-expressed with MHC class I molecules and a putative peptide transporter.
• LMP7 and LMP2 polypeptides undergo proteolytic processing upon incorporation into proteasomes.
• The LMP7 precursor is primarily derived from LMP7-E2.
• LMP7 and LMP2 exhibit mutual dependence for their incorporation into the proteasomal complex.

Conclusions:

• Alternative splicing of the LMP7 gene generates distinct transcripts, influencing proteasome composition.
• LMP2 and LMP7 are integral components of the antigen processing machinery, coordinated with MHC expression.
• The functional incorporation of LMP2 and LMP7 into proteasomes is interdependent, highlighting complex regulatory mechanisms.